Canadians pay very high drug costs, but Canada also does not receive the same economic benefits from pharmaceutical industry investments as other countries do.
Academic rigor, journalistic flair
Articles on Drug manufacturing
Displaying all articles
COVID-19 has exacerbated a backlog of domestic and foreign drug manufacturing inspections that the FDA is still too short-staffed to adequately deal with.
The FDA receives almost half its funding from companies it regulates, such as drug and medical device makers. Is this something you should be concerned about?
Vaccine manufacturing is complex, with lots of potential points for errors. But it also has extensive quality control checks and approvals.
There are ingredients in your pills other than the one designed to treat your ailments. Those unnamed ingredients can alter how you respond to a medicine or even make you sick.
Top contributors
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor of Operations Management & Business Analytics, Carey Business School, Johns Hopkins University
-
Postdoctoral Fellow in Quality of Medical Products, University of California, San Francisco
-
Associate Professor of Comparative Effectiveness and Outcomes Research, University of Connecticut
-
Clinical Professor, UBC Division of Endocrinology, University of British Columbia
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
